CRP and metabolic syndrome: For instance, an 8-week co-administration of piperine (at 10 mg) with curcuminoids (at 1 g) could improve oxidative and inflammatory status by enhancing serum levels of SOD while reducing those of malonaldehyde (MDA) and C-reactive protein in individuals with metabolic syndrome [142].